Thorsten Waloschek: Addressing Risks in Pregnancies with Sclerosis
Thorsten Waloschek, CEO of NeoPredics AG, shared a post on LinkedIn:
“A new study from The Lancet Rheumatology caught my attention this week.
It examines pregnancy outcomes in women with systemic sclerosis and highlights a reality we still need to confront. Even with a high live birth rate, the risks for mothers remain significantly elevated, particularly when it comes to preeclampsia, placental insufficiency, preterm birth, and severe postpartum complications.
Pregnancy places an extraordinary cardiovascular demand on the body, and for women with underlying autoimmune or vascular conditions, those risks can rise sharply. What concerns me most is that nearly 40 percent of pregnancies in the study showed worsening disease during pregnancy or within the first year postpartum. It reinforces something many in maternal health already know: we still lack effective, accessible tools for early risk detection.”
Read more.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Apr 15, 2026, 16:38Why an Ovulation Trigger Shot Sometimes Fails – Fertility Plus
-
Apr 15, 2026, 16:3374 New Studies Added to the AC Forum Literature Library – Anticoagulation Forum
-
Apr 15, 2026, 16:23Insights from PGT-A in Recurrent IVF Failure – Motherhood Training Center
-
Apr 15, 2026, 16:20Effect of Endometriosis and Adenomyosis on Oocyte Quality and Morphology – RBMO
-
Apr 15, 2026, 11:37Ally Murji: Honoured to be Part of the Canadian Session at the SEUD Meeting
-
Apr 15, 2026, 11:00Scammers are Targeting ESHRE2026 Attendees With Fake Registration and Hotel Offers – ESHRE
-
Apr 15, 2026, 10:24Join Us This Friday for Our “Research in Progress” – SRF
-
Apr 15, 2026, 10:20The Importance of Fertility Preservation in Turner Syndrome – RBMO
-
Apr 15, 2026, 10:16Marlena Fejzo: Our Study Identifying 6 New Genes Associated with Hyperemesis Gravidarum